A director at Unilever Plc sold after exercising options/sold 18,486 shares at 5,414p and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
AEGON: Uneventful results, US weaker, underlying OCG in line / Air France-KLM: Productivity gains starting to filter through / Arcadis: Weak revenues and EBITA, but strong NWC / Ascencio: Results in line, no concerns on Carrefour Belgium exposure / Azelis: Persisting softness in 4Q25, continued focus on costs and cash / BAM Group: Solid 2H25 results, 2026 outlook in line / Belgian telecoms: Telenet improved net adds, to relist as part of Ziggo in 2027, Liberty to sell half of its 66% Wyre stake ...
4Q'25 vs. 4Q'24 Results Sales: € 1.446 Bn (+6.2% vs. +2.7% BS(e) and +2.9% consensus); FY2025 vs. FY2024 Results Sales: € 5.042 Bn (+5.3% vs. +4.3% BS(e) and +4.3% consensus); Adjusted EBITDA: € 1.045 Bn (+7.8% vs. +5.2% BS(e) and +5.1% consensus); EBIT: € 834.46 M (+36.3% vs. +30.7% BS(e) and +28.9% consensus); Net Profit: € 593.7 M (+11.8% vs. +14.3% BS(e) and +12.8% consensus);
Rdos. 4T'25 vs 4T'24: Ventas: 1.446 M euros (+6,2% vs +2,7% BS(e) y +2,9% consenso). Rdos. 2025 vs 2024: Ventas: 5.042 M euros (+5,3% vs +4,3% BS(e) y +4,3% consenso); EBITDA ajustado: 1.045 M euros (+7,8% vs +5,2% BS(e) y +5,1% consenso); EBIT: 834,46 M euros (+36,3% vs +30,7% BS(e) y +28,9% consenso); BDI: 593,7 M euros (+11,8% vs +14,3% BS(e) y +12,8% consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: MELIÁ HOTELES, MERLIN PROPERTIES, PUIG BRANDS. EUROPA: BAYER, ESSILORLUXOTTICA. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. El Ibex se prepara para atacar nuevamente los 18.000 puntos Las bolsas europeas arrancaron la sesión con dudas, per...
NEWS SUMMARY: MELIÁ HOTELS, MERLIN PROPERTIES, PUIG BRANDS. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. IBEX ready to attack 18,000 once again European stock markets began the session hesitantly, but ended by recovering the momentum in a session marked by the talks between the US and Iran regarding Iran’s nuclear p...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 16 February 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026. Under the programme initiated 4 February 2026, Novo Nordisk will rep...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.